Cart
sales@molnova.com
Neocurdione
CAS No. 108944-67-8
Neocurdione( ——— )
Catalog No. M38707 CAS No. 108944-67-8
Neocurdione is a hepatoprotective sesquiterpene isolated from Curcuma zedoaria rhizome. Neocurdione exerts potent effect on D-galactosamine- (D-Gain) and lipopolysaccharide- (LPS) induced acute liver injury in mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNeocurdione
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeocurdione is a hepatoprotective sesquiterpene isolated from Curcuma zedoaria rhizome. Neocurdione exerts potent effect on D-galactosamine- (D-Gain) and lipopolysaccharide- (LPS) induced acute liver injury in mice.
-
DescriptionNeocurdione is an attachment inhibitor against the blue mussel, Mytilus edulis galloprovincialis.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayApoptosis
-
TargetTNF
-
RecptorNO Synthase;TNF-α;Caspase
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number108944-67-8
-
Formula Weight236.355
-
Molecular FormulaC15H24O2
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Carvalho FR, et al. Journal of Venomous Animals and Toxins including Tropical Diseases.On-line version ISSN 1678-9199
molnova catalog
related products
-
Certolizumab pegol
Certolizumab pegol (Certolizumab) is a polyethylene glycolated and humanized anti-TNF-α monoclonal antibody for the study of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).
-
Thalidomide
Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
-
MALTOTETRAOSE
MALTOTETRAOSE are potent inhibitors of TNF-α-induced intercellular adhesion molecule-1 (ICAM-1) expression maltotetraose may be beneficial in the suppression of early atherosclerosis development.
